| Issue |
Med Sci (Paris)
Volume 34, Number 11, Novembre 2018
|
|
|---|---|---|
| Page(s) | 999 - 1002 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/2018216 | |
| Published online | 10 December 2018 | |
Cancer
Thérapies « complémentaires » et observance du traitement anti-tumoral font-elles bon ménage ?
Are « complementary » cancer therapies actually indirectly harmful?
UMR 7268 ADÉS, Aix-Marseille, Université/EFS/ CNRS ; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France
Abstract
A recent paper shows that cancer patients using complementary therapies in addition to conventional treatment have distinctly worse outcomes. Analysis of the data shows that they are much more likely to refuse one component of conventional treatment: this explains the negative effects of recourse to complementary approaches and underlines the need for great caution in approving their use while ensuring correct adherence to the anti-tumour treatment.
© 2018 médecine/sciences – Inserm
Article publié sous les conditions définies par la licence Creative Commons Attribution License CC-BY (http://creativecommons.org/licenses/by/4.0), qui autorise sans restrictions l’utilisation, la diffusion, et la reproduction sur quelque support que ce soit, sous réserve de citation correcte de la publication originale.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.